MedPath

Injecting Platelet rich plasma in women with thin inner lining of the womb who are undergoing assisted fertility treatment

Not Applicable
Conditions
Health Condition 1: X- New Technology
Registration Number
CTRI/2023/04/052136
Lead Sponsor
All India Institute of Medical Sciences New Delhi
Brief Summary

Not available

Detailed Description

Not available

Recruitment & Eligibility

Status
ot Yet Recruiting
Sex
Not specified
Target Recruitment
0
Inclusion Criteria

Patients with thin endometrium ( <6 mm) refractory to standard treatment by estrogen-

1. on the day of ovulation trigger in previous fresh Embryo transfer (ET) cycle, OR

2. at the end of estrogen priming in previous frozen embryo transfer (FET) cycle, OR

3. on day of ovulation trigger in previous IUI cycles, OR.

4. on baseline scans (mock cycles), despite standard estrogen supplementation (6-12 mg/day) for 12 days

5. Willing to participate in the study

Exclusion Criteria

1. Hematologic disorders, hemoglobin level of <11.0 g/dL or platelet count of <150,000/μl

2. Auto-immune disease

3. Evidence of genital tuberculosis

4. Any factor that compromises implantation, other than endometrium,e.g. Hydrosalpinx (unclipped), Adenomyosis

5. Refusal to participate

Study & Design

Study Type
Interventional
Study Design
Not specified
Primary Outcome Measures
NameTimeMethod
Secondary Outcome Measures
NameTimeMethod
© Copyright 2025. All Rights Reserved by MedPath